Johannes Hulthe

Johannes Hulthe is a declared insider of Guard Therapeutics International AB (publ) (board member), with filings sourced from Finansinspektionen. In total, 5 filings cover trades dated from 2 March 2022 to 4 April 2025.

Purchases make up the whole of the open-market record (3 purchases, €33k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

In size, the median ticket on the buying side is €641. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 9 April 2025, reports a transaction in Guard Therapeutics International AB (publ). The last insider purchase was made public on 21 September 2023, 1,144 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.